CIK: 0001816307 · Show all filings
Period: Q4 2022 (← Previous) (Next →)
Filing Date: Feb 14, 2023
Total Value ($000): $349,550 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | Prometheus Bioscience, Inc. | 172,400 | $18,964 | 5.4% | $110.00 | — | Put | 74349U108 |
| MDGL | Madrigal Pharmaceuticals Inc | 49,898 | $14,483 | 4.1% | $97.80 | 0.0% | EQUITIES | 558868105 |
| — | Bellus Health Inc | 1,707,370 | $14,035 | 4.0% | $7.01 | — | EQUITIES | 07987C204 |
| — | Poseida Therapeutics Inc | 2,230,000 | $11,819 | 3.4% | $3.78 | — | EQUITIES | 73730P108 |
| VRAYQ | Viewray Inc | 2,405,360 | $10,776 | 3.1% | $3.81 | +14.0% | EQUITIES | 92672L107 |
| XENE | Xenon Pharmaceuticals Inc | 253,655 | $10,002 | 2.9% | $29.63 | +22.9% | EQUITIES | 98420N105 |
| — | Akero Therapeutics Inc | 172,100 | $9,431 | 2.7% | $12.70 | — | EQUITIES | 00973Y108 |
| AVXL | Anavex Life Science Corp | 1,007,700 | $9,331 | 2.7% | — | — | Put | 032797300 |
| IMVT | Immunovant Inc | 519,614 | $9,223 | 2.6% | $8.14 | +54.6% | EQUITIES | 45258J102 |
| NUVL | Nuvalent Inc | 302,963 | $9,022 | 2.6% | $26.36 | +5.8% | EQUITIES | 670703107 |
| — | Morphic Holding Inc | 334,535 | $8,949 | 2.6% | $25.74 | — | EQUITIES | 61775R105 |
| ALNY | Alnylam Pharmaceuticals Inc | 37,652 | $8,948 | 2.6% | $193.80 | +10.1% | EQUITIES | 02043Q107 |
| MDGL | Madrigal Parmaceuticals, Inc. | 30,000 | $8,708 | 2.5% | $97.80 | 0.0% | Put | 558868105 |
| — | Akero Therapeutics Inc | 150,000 | $8,220 | 2.4% | $12.70 | — | Call | 00973Y108 |
| — | Akero Therapeutics Inc | 150,000 | $8,220 | 2.4% | $12.70 | — | Put | 00973Y108 |
| — | Intra-Cellular Therapies Inc | 140,366 | $7,428 | 2.1% | $49.08 | — | EQUITIES | 46116X101 |
| ORIC | Oric Pharmaceuticals Inc | 1,236,296 | $7,282 | 2.1% | $3.98 | -15.1% | EQUITIES | 68622P109 |
| TERN | Terns Pharmaceuticals Inc | 700,000 | $7,126 | 2.0% | $6.60 | +0.9% | EQUITIES | 880881107 |
| — | Mersana Therapeutics Inc | 1,140,182 | $6,681 | 1.9% | $5.05 | — | EQUITIES | 59045L106 |
| BIIB | Biogen Idec Inc | 21,975 | $6,085 | 1.7% | $282.44 | 0.0% | EQUITIES | 09062X103 |
| CERS | Cerus Corp | 1,634,014 | $5,964 | 1.7% | $5.67 | -33.4% | EQUITIES | 157085101 |
| CVRX | Cvrx Inc | 314,584 | $5,773 | 1.7% | $6.00 | +105.7% | EQUITIES | 126638105 |
| ACRS | Aclaris Therapeutics Inc | 352,193 | $5,547 | 1.6% | $15.96 | +0.8% | EQUITIES | 00461U105 |
| — | Prometheus Biosciences Inc | 50,000 | $5,500 | 1.6% | $110.00 | — | EQUITIES | 74349U108 |
| — | Cincor Pharma Inc | 395,382 | $4,859 | 1.4% | $12.29 | — | EQUITIES | 17240Y109 |
| GSK | GlaxoSmithKline PLC | 136,178 | $4,785 | 1.4% | $35.14 | — | EQUITIES | 37733W204 |
| VCYT | Veracyte Inc | 200,000 | $4,746 | 1.4% | $30.89 | -24.8% | EQUITIES | 92337F107 |
| KRYS | Krystal Biotech Inc | 58,535 | $4,637 | 1.3% | $60.89 | +21.9% | EQUITIES | 501147102 |
| BCAB | Bioatla Inc | 546,875 | $4,512 | 1.3% | $7.66 | +8.4% | EQUITIES | 09077B104 |
| UTHR | United Therapeutics Corp | 16,048 | $4,463 | 1.3% | $203.99 | +23.8% | EQUITIES | 91307C102 |
| GILD | Gilead Sciences Inc | 51,962 | $4,461 | 1.3% | $70.79 | 0.0% | EQUITIES | 375558103 |
| PRTA | Prothena Corporation PLC | 71,706 | $4,320 | 1.2% | $31.61 | +85.2% | EQUITIES | G72800108 |
| — | Merus NV | 274,704 | $4,250 | 1.2% | $21.56 | — | EQUITIES | N5749R100 |
| PLRX | Pliant Therapeutics Inc | 217,503 | $4,204 | 1.2% | $19.20 | +8.9% | EQUITIES | 729139105 |
| MGNX | MacroGenics Inc | 612,475 | $4,110 | 1.2% | $5.21 | +5.2% | EQUITIES | 556099109 |
| — | Allakos Inc | 480,701 | $4,048 | 1.2% | $6.51 | — | EQUITIES | 01671P100 |
| PCVX | Vaxcyte Inc | 83,135 | $3,986 | 1.1% | $39.24 | 0.0% | EQUITIES | 92243G108 |
| IMTX | Immatics Nv | 439,788 | $3,831 | 1.1% | $10.84 | -4.6% | EQUITIES | N44445109 |
| VRTX | Vertex Pharmaceuticals Inc | 11,384 | $3,287 | 0.9% | $230.60 | +32.2% | EQUITIES | 92532F100 |
| BCRX | BioCryst Pharmaceuticals Inc | 272,173 | $3,125 | 0.9% | $13.37 | -6.7% | EQUITIES | 09058V103 |
| — | Point Biopharma Global Inc | 400,812 | $2,922 | 0.8% | $7.62 | — | EQUITIES | 730541109 |
| RNAM | Avidity Biosciences Inc | 128,000 | $2,840 | 0.8% | $14.91 | 0.0% | EQUITIES | 05370A108 |
| ASND | Ascendis Pharma A/S | 23,151 | $2,827 | 0.8% | $118.04 | — | EQUITIES | 04351P101 |
| CRNX | Crinetics Pharmaceuticals Inc | 152,747 | $2,795 | 0.8% | $22.16 | -20.5% | EQUITIES | 22663K107 |
| PHR | Phreesia Inc | 85,390 | $2,763 | 0.8% | $22.32 | +21.6% | EQUITIES | 71944F106 |
| ALT | Altimmune, Inc. | 160,000 | $2,632 | 0.8% | $14.76 | -23.9% | Call | 02155H200 |
| — | Horizon Therapeutics Plc | 23,054 | $2,624 | 0.8% | $102.06 | — | EQUITIES | G46188101 |
| INSM | Insmed Inc | 124,465 | $2,487 | 0.7% | $28.18 | -31.4% | EQUITIES | 457669307 |
| CLDX | Celldex Therapeutics Inc | 54,699 | $2,438 | 0.7% | $38.41 | -7.1% | EQUITIES | 15117B202 |
| CGEM | Cullinan Oncology Inc | 229,416 | $2,420 | 0.7% | $11.46 | +6.0% | EQUITIES | 230031106 |
| — | Seres Therapeutics Inc | 374,422 | $2,097 | 0.6% | $9.37 | — | EQUITIES | 81750R102 |
| COGT | Cogent Biosciences Inc | 179,000 | $2,069 | 0.6% | $7.94 | +56.2% | EQUITIES | 19240Q201 |
| — | ImmunoGen Inc | 407,269 | $2,020 | 0.6% | $7.00 | — | EQUITIES | 45253H101 |
| SDGR | Schrodinger Inc | 108,000 | $2,019 | 0.6% | $20.73 | 0.0% | EQUITIES | 80810D103 |
| — | IVERIC bio Inc | 88,243 | $1,889 | 0.5% | $17.94 | — | EQUITIES | 46583P102 |
| ABOS | Acumen Pharmaceuticals Inc | 295,115 | $1,594 | 0.5% | $5.74 | +17.1% | EQUITIES | 00509G209 |
| — | LAVA Therapeutics NV | 437,762 | $1,532 | 0.4% | $4.57 | — | EQUITIES | N51517105 |
| — | CTI BioPharma Corp | 254,361 | $1,529 | 0.4% | $3.23 | — | EQUITIES | 12648L601 |
| CLYM | Eliem Therapeutics Inc | 409,202 | $1,502 | 0.4% | $5.26 | -43.7% | EQUITIES | 28658R106 |
| TRVI | Trevi Therapeutics Inc | 767,631 | $1,482 | 0.4% | $3.28 | -39.9% | EQUITIES | 89532M101 |
| — | Seagen Inc | 11,016 | $1,416 | 0.4% | $173.78 | — | EQUITIES | 81181C104 |
| — | Amryt Pharma PLC | 192,995 | $1,409 | 0.4% | $12.40 | — | EQUITIES | 03217L106 |
| CMPX | Compass Therapeutics Inc. | 268,307 | $1,350 | 0.4% | $2.80 | +42.6% | EQUITIES | 20454B104 |
| — | Astria Therapeutics Inc | 81,204 | $1,209 | 0.3% | $14.89 | — | EQUITIES | 04635X102 |
| — | ImmunoGen, Inc. | 232,000 | $1,151 | 0.3% | $7.00 | — | Call | 45253H101 |
| NTLA | Intellia Therapeutics Inc | 32,770 | $1,143 | 0.3% | $61.70 | -22.9% | EQUITIES | 45826J105 |
| PHVS | Pharvaris NV | 100,000 | $1,125 | 0.3% | $5.25 | 0.0% | EQUITIES | N69605108 |
| — | Aerovate Therapeutics Inc | 36,906 | $1,081 | 0.3% | $29.30 | — | EQUITIES | 008064107 |
| AVXL | Anavex Life Science Corp | 102,600 | $950 | 0.3% | — | — | Call | 032797300 |
| — | Veru Inc. | 175,000 | $924 | 0.3% | — | — | Put | 92536C103 |
| CUE | Cue Biopharma Inc | 306,278 | $873 | 0.2% | $3.05 | 0.0% | EQUITIES | 22978P106 |
| ALT | Altimmune Inc | 50,546 | $831 | 0.2% | $14.76 | -23.9% | EQUITIES | 02155H200 |
| CYTK | Cytokinetics Inc | 17,500 | $802 | 0.2% | $42.95 | 0.0% | EQUITIES | 23282W605 |
| AXSM | Axsome Therapeutics Inc | 10,000 | $771 | 0.2% | $59.77 | 0.0% | EQUITIES | 05464T104 |
| STXS | Stereotaxis Inc | 354,925 | $735 | 0.2% | $7.15 | -72.7% | EQUITIES | 85916J409 |
| CDXS | Codexis Inc | 144,737 | $674 | 0.2% | $16.86 | -67.5% | EQUITIES | 192005106 |
| DSGN | Design Therapeutics Inc | 57,025 | $585 | 0.2% | $13.55 | 0.0% | EQUITIES | 25056L103 |
| IMUX | Immunic Inc | 350,656 | $491 | 0.1% | $2.73 | 0.0% | EQUITIES | 4525EP101 |
| CGEN | Compugen Ltd | 667,443 | $478 | 0.1% | $0.87 | 0.0% | EQUITIES | M25722105 |
| MGTX | Meiragtx Holdings Plc | 56,672 | $370 | 0.1% | $9.58 | -28.4% | EQUITIES | G59665102 |
| WVE | WAVE Life Sciences Ltd | 50,000 | $350 | 0.1% | $4.61 | 0.0% | EQUITIES | Y95308105 |
| BRZE | Braze Inc | 10,000 | $273 | 0.1% | $27.92 | 0.0% | EQUITIES | 10576N102 |
| — | Praxis Precision Medicines Inc | 98,409 | $234 | 0.1% | $2.27 | — | EQUITIES | 74006W108 |
| QURE | Uniqure NV | 10,000 | $227 | 0.1% | $21.57 | 0.0% | EQUITIES | N90064101 |
| GOSS | Gossamer Bio Inc | 100,000 | $217 | 0.1% | $8.23 | 0.0% | EQUITIES | 38341P102 |
| — | Evogene Ltd | 150,361 | $105 | 0.0% | $4.20 | — | EQUITIES | M4119S104 |
| VRDN | Viridian Therapeutics Inc | 3,000 | $88 | 0.0% | $23.04 | 0.0% | EQUITIES | 92790C104 |
| ELOX | Eloxx Pharmaceuticals Inc | 26,876 | $49 | 0.0% | $4.83 | 0.0% | EQUITIES | 29014R202 |
| — | Fresh Tracks Therapeutics Inc | 10,000 | $15 | 0.0% | $1.50 | — | EQUITIES | 10802T204 |
| — | Medicus Sciences Acquisition Corp | 49,990 | $4 | 0.0% | $1.00 | — | WARRANTS | G5960S124 |